Recall Ledger

STA Staclot Protein S recall (Diagnostica Stago, Inc.)

Medical deviceClass IIOngoing

Summary: Diagnostica Stago, Inc. is recalling STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiency test. Reason: A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified.

What is being recalled

STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiency test

Why

A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified

How serious is it

Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.

Where it was sold

US Nationwide distribution in the states and territory of NJ, NY, NJ, VA, PA, FL, AL, GA, TN, OH, IL, MO, NE, TX, CO, UT, CA, PR. (states named: Alabama, California, Colorado, Florida, Georgia, Illinois, Missouri, Nebraska, New Jersey, New York, Ohio, Pennsylvania, Puerto Rico, Tennessee, Texas, Utah, Virginia)

How to tell if yours is affected

UDI : (01)3607450007466(11)250331(17)270331(10)273074(241)00746, Exp 3/31/2027

What to do

Check the model, lot or serial numbers above against your device. If yours is affected, contact the manufacturer or your healthcare provider before you stop using a device you rely on.

Recall facts

Recall numberZ-3047-2026
CategoryMedical device
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass II
StatusOngoing
Recall startedJuly 29, 2026
ReportedSeptember 9, 2026
CompanyDiagnostica Stago, Inc.
Company locationParsippany, NJ, United States
Initiated byVoluntary: Firm initiated
Quantity5220 units

More recalls from Diagnostica Stago, Inc. · all medical device recalls · recalls from July 2026

Official FDA record